255 related articles for article (PubMed ID: 11001901)
1. Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization.
Mondoro TH; White MM; Jennings LK
Blood; 2000 Oct; 96(7):2487-95. PubMed ID: 11001901
[TBL] [Abstract][Full Text] [Related]
2. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
Jennings LK; White MM; Mandrell TD
Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
[TBL] [Abstract][Full Text] [Related]
3. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
Mondoro TH; Wall CD; White MM; Jennings LK
Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
[TBL] [Abstract][Full Text] [Related]
4. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
Mousa SA; Khurana S; Forsythe MS
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1162-7. PubMed ID: 10764688
[TBL] [Abstract][Full Text] [Related]
6. The effect of glycoprotein IIb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets.
Kouns WC; Fox CF; Lamoreaux WJ; Coons LB; Jennings LK
J Biol Chem; 1991 Jul; 266(21):13891-900. PubMed ID: 1906886
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
Sloan SM; Brown EB; Liu Q; Frojmovic MM
Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
9. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of the platelet integrin alphaIIbbeta3 (GPIIb-IIIa) to talin. Evidence that interaction is mediated through the cytoplasmic domains of both alphaIIb and beta3.
Knezevic I; Leisner TM; Lam SC
J Biol Chem; 1996 Jul; 271(27):16416-21. PubMed ID: 8663236
[TBL] [Abstract][Full Text] [Related]
11. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction.
Rooney MM; Farrell DH; van Hemel BM; de Groot PG; Lord ST
Blood; 1998 Oct; 92(7):2374-81. PubMed ID: 9746777
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies bound to subunits of the integrin GPIIb-IIIa are internalized and interfere with filopodia formation and platelet aggregation.
Isenberg WM; Bainton DF; Newman PJ
Blood; 1990 Oct; 76(8):1564-71. PubMed ID: 2207330
[TBL] [Abstract][Full Text] [Related]
13. Regulation of clot retraction by glycoprotein IIb/IIIa antagonists.
Seiffert D; Pedicord DL; Kieras CJ; He B; Stern AM; Billheimer JT
Thromb Res; 2002 Nov; 108(2-3):181-9. PubMed ID: 12590956
[TBL] [Abstract][Full Text] [Related]
14. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
15. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
16. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots.
Schoenwaelder SM; Yuan Y; Cooray P; Salem HH; Jackson SP
J Biol Chem; 1997 Jan; 272(3):1694-702. PubMed ID: 8999848
[TBL] [Abstract][Full Text] [Related]
17. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics.
Weber AA; Schrör K
Blood; 2001 Sep; 98(5):1619-21. PubMed ID: 11520817
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists.
Jennings LK; Haga JH; Slack SM
Thromb Haemost; 2000 Dec; 84(6):1095-102. PubMed ID: 11154119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
